Beth Muir

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

Jianmin Zhang, C. Deng, D. Sgroi, 2006, Proceedings of the National Academy of Sciences.

The Spemann organizer gene, Goosecoid, promotes tumor metastasis

Anne E Carpenter, Anne E. Carpenter, Dennis C. Sgroi, 2006, Proceedings of the National Academy of Sciences.

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

Wei Wang, R. Salunga, Xiao-Jun Ma, 2004, Cancer cell.

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Janusz Jankowski, David Ferry, Patricia L. Harris, 2006, Clinical Cancer Research.

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.

Patricia L. Harris, G. Giaccone, M. Kris, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR

Patricia L. Harris, D. Sgroi, D. Haber, 2005, Clinical Cancer Research.

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

Gayatry Mohapatra, D. Sgroi, D. Haber, 2006, Proceedings of the National Academy of Sciences of the United States of America.

The Prognostic Biomarkers HOXB13, IL17BR, and CHDH Are Regulated by Estrogen in Breast Cancer

K. Coser, Xiao-Jun Ma, D. Sgroi, 2007, Clinical Cancer Research.

Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.

L. Chin, M. Rivera, C. Deng, 2006, Cancer research.